FanGraphs Chat – 2/6/13

Print This Post

Dave is a co-founder of and contributes to the Wall Street Journal.

8 Responses to “FanGraphs Chat – 2/6/13”

You can follow any responses to this entry through the RSS 2.0 feed.
  1. wobatus says:

    If Wedge says Smoak plays first and Montero catches, Ibanez doesn’t really have a job, does he? I suppose he could get the odd start in left against a tough righty with Morse sitting, and at times sub in for Morales or Smoak with Kendrys going to first. I see no need for Bay at all.

    Vote -1 Vote +1

  2. LaLoosh says:

    DC, can you point me to the section in the CBA that you said expressly prohibits a sign and trade that would expressly be to circumvent the compensation issue? I’m sure it’s there but didn’t see it.

    Vote -1 Vote +1

  3. Nitram Odarp says:

    Did Dave really claim we don’t know enough to say Braun almost certainly used steroids? The only possible reason to think he didn’t is if you think the collector somehow managed to open three tamper proof seals without leaving a trace of evidence that he had done so, but if you believe that then you might as well not trust any positive test since anyone could be tampered with if you don’t trust the seals.

    There is a reason the WADA said Braun would have lost his appeal in their system. They actually force the athletes to show that any lapses in protocol could have caused the positive test, and Braun had no case as to how the collector could have caused a failed IRMS test. Unfortunately, the MLB CBA allows players to get off much easier than the WADA. Even though there is no evidence to support Braun’s initial result being inaccurate, he got let off the hook on a technicality.

    Vote -1 Vote +1

    • Johnny Come Lately says:

      Just because he got off on this specific technicality, doesn’t mean that there weren’t other avenues that could’ve allowed him to win his appeal. There could’ve been 10 things wrong, and this one proved the easiest to argue. The fact is, we have no idea.

      Vote -1 Vote +1

      • Nitram Odarp says:

        He would have made that argument in the court of public opinion if he could have. The fact is there is no argument against the IRMS positive other than the collector tampering with three tamper proof seals without leaving any evidence of doing so. I mean it is possible that could have happened, but it is far, far, far, far, far more likely he simply used and got off on a technicality.

        Vote -1 Vote +1

  4. JWard says:

    It’s quite tiring to hear the word ‘value’ over and over and over again. can’t you use ‘production’ instead? ‘He provded good value’ has no real meaining and sounds like an Economics phrase.

    Vote -1 Vote +1

  5. Moonraker says:

    DC: “The Dodgers, with all their spending, missed the playoffs last year. The A’s, Rays, and O’s made the playoffs. It’s not just about money.”

    The Rays didn’t make the playoffs last year, but they did win 90 games.

    Vote -1 Vote +1

  6. Undocorkscrew says:

    You also have to include having a full season(hopefully) of Andrelton Simmons over the abysmal Pastornicky/Janish due they saw for the majority of last season. Shoulder injuries are always scary, but I can see McCann bouncing back to a respectable slash line with 18-20 HR(around 3.0-3.5 WAR). A return to form for him could be huge.

    Teheran clearly has potential to be special, but he can’t be all that worse than Hanson was last season. I see Medlen as a 4-win player over the course of a full season, so I don’t expect him to provide more value than he did last year. I do expect more consistency out of Mike Minor though. Call me crazy, but I like this rotation and bullpen more than last year’s group(though I don’t expect another historic season from Kimbrel). They do lack SP depth, but Hudson, Medlen, Minor, Maholm, Teheran is a very solid group. Assuming they can get 8-9 starts out of Beachy could help close the gap.

    In any case, I’d be thrilled with another 94-win season.

    Vote -1 Vote +1

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>